Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BIND Therapeutics Inc

+ Add to Watchlist

BIND:US

5.7200 USD 0.1000 1.72%

As of 16:30:00 ET on 05/22/2015.

Snapshot for BIND Therapeutics Inc (BIND)

Open: 5.8200 Day's Range: 5.6400 - 5.8699 Volume: 149,998
Previous Close: 5.8200 52wk Range: 4.8900 - 13.7200 1-Yr Rtn: -35.29%

Stock Chart for BIND

No chart data available.
  • BIND:US 5.7200
  • 1D
  • 1M
  • 1Y
5.8200
Interactive BIND Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIND

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.9033
Est. EPS (USD) (12/2015) -1.9020
Est. PEG Ratio -
Market Cap (M USD) 116.04
Shares Outstanding (M) 20.39
30 Day Average Volume 379,487
Price/Book (mrq) 2.7926
Price/Sale (ttm) 7.4388
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIND

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIND

BIND Therapeutics, Inc provides clinical-stage nanomedicine platform. The Company develops targeted and programmable therapeutics to active pharmaceutical ingredients in diseased tissues.

Andrew J HirschPresident/CEODan KoerwerChief Business Officer
Hagop YoussoufianChief Medical OfficerChristopher M LindblomSenior VP:Finance & Admin/Treasurer
More Company Profile & Key Executives for BIND

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil